Serum Cystatin C and Coronavirus Disease 2019: A Potential Inflammatory Biomarker in Predicting Critical Illness and Mortality for Adult Patients
This study aimed at determining the relationship between baseline cystatin C levels and coronavirus disease 2019 (COVID-19) and investigating the potential prognostic value of serum cystatin C in adult patients with COVID-19. 481 patients with COVID-19 were consecutively included in this study from...
Saved in:
Main Authors: | Dan Chen (Author), Wenwu Sun (Author), Jia Li (Author), Bohua Wei (Author), Wei Liu (Author), Xiaopin Wang (Author), Fan Song (Author), Liangkai Chen (Author), Junhui Yang (Author), Li Yu (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum Creatinine and Serum Cystatin C are Both Relevant Renal Markers to Estimate Vancomycin Clearance in Critically Ill Neonates
by: Stéphanie Leroux, et al.
Published: (2021) -
Critically ill infant with coronavirus disease 2019
by: Pallavi, et al.
Published: (2020) -
Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma
by: Nada E. Hammouda, et al.
Published: (2017) -
Serum cystatin C concentration levels as a marker of acute renal failure in critically ill patients - A cross section study
by: A.R. Shoukath, et al.
Published: (2014) -
Creatinine and Cystatin C: Markers of Poor Outcome in Critically Ill COVID-19 Patients?
by: Duarte André Ferreira, et al.
Published: (2023)